IP Library › Granted Patent US 9,682,236
Granted Patent B2
US 9,682,236 · App. 15/001,096 · Granted Jun 20, 2017

Devices, systems and methods for treatment of neuropsychiatric disorders

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,682,236
App. No.
15/001,096
Granted
Jun 20, 2017
Kind
B2
Abstract

The present disclosure relates to methods, devices and systems used for the treatment of mood, anxiety, post traumatic stress disorder, and cognitive and behavioral disorders (collectively, neuropsychiatric disorders) via stimulation of the superficial elements of the trigeminal nerve (“TNS”). More specifically, cutaneous methods of stimulation of the superficial branches of the trigeminal nerve located extracranially in the face, namely the supraorbital, supratrochlear, infraorbital, auriculotemporal, zygomaticotemporal, zygomaticoorbital, zygomaticofacial, infraorbital, nasal and mentalis nerves (also referred to collectively as the superficial trigeminal nerve) are disclosed herein.

Claims (30)

1. A cutaneous electrode assembly for stimulation of trigeminal nerves to treat a neuropsychiatric disorder, the cutaneous electrode assembly comprising:

a first contact configured for placement on a first region of a patient's face;

a second contact configured for placement on a second region of the patient's face; and

an insulating connection region connecting the first contact and the second contact, wherein the first contact and the second contact are spaced apart according to a distance between a first cutaneous distribution of the trigeminal nerves and a second cutaneous distribution of the trigeminal nerves.

2. The cutaneous electrode assembly of claim 1 , wherein the trigeminal nerves to be stimulated comprise a superficial ophthalmic branch, an infraorbital branch, a mentalis branch, or a combination thereof.

3. The cutaneous electrode assembly of claim 1 , wherein the trigeminal nerves to be stimulated comprise a supraorbital nerve.

4. The cutaneous electrode assembly of claim 1 , wherein the trigeminal nerves to be stimulated comprise an auriculotemporal nerve.

5. The cutaneous electrode assembly of claim 1 , wherein the trigeminal nerves to be stimulated comprise a zygomaticofacial nerve.

6. The cutaneous electrode assembly of claim 1 , further comprising a retainer element configured to secure the cutaneous electrode assembly to the patient's face.

7. The cutaneous electrode assembly of claim 1 , wherein the neuropsychiatric disorder is depression, post-traumatic stress disorder, a mood disorder, an anxiety disorder, a cognitive disorder, a behavioral disorder, or a combination thereof.

8. A kit for the stimulation of the trigeminal nerve to treat the neuropsychiatric disorder or condition, the kit comprising:

the cutaneous electrode assembly according to claim 1 ; and

instructions for placement of the electrode assembly on a patient for treatment of a neuropsychiatric disorder.

9. The kit of claim 8 , further comprising:

a neurostimulator; and

instructions for applying electrical signals to the electrode assembly for treatment of a neuropsychiatric disorder.

10. A system for stimulation of trigeminal nerves to treat a neuropsychiatric disorder or condition, the system comprising:

a neurostimulator; and

a cutaneous electrode assembly comprising:

a first contact configured for placement on a first region of a patient's face;

a second contact configured for placement on a second region of the patient's face; and

an insulating connection region connecting the first contact and the second contact, wherein the first contact and the second contact are spaced apart according to a distance between a first cutaneous distribution of the trigeminal nerves and a second cutaneous distribution of the trigeminal nerves.

11. The system of claim 10 , further comprising a cable and lead wires operably connecting the neurostimulator and the cutaneous electrode assembly.

12. The system of claim 10 , further comprising a regulation device configured to regulate current output to minimize or prevent current penetration below the surface of the skull bone.

13. The system of claim 10 , further comprising a retainer element configured to secure the cutaneous electrode assembly to the patient's face.

14. The system of claim 10 , wherein the trigeminal nerves to be stimulated comprise a superficial ophthalmic branch, an infraorbital branch, a mentalis branch, or a combination thereof.

15. The system of claim 10 , wherein the trigeminal nerves to be stimulated comprise a supraorbital nerve.

16. The system of claim 10 , wherein the trigeminal nerves to be stimulated comprise an auriculotemporal nerve.

17. The system of claim 10 , wherein the trigeminal nerves to be stimulated comprise an zygomaticofacial nerve.

18. The system of claim 10 , wherein the neuropsychiatric disorder is depression, post-traumatic stress disorder, a mood disorder, an anxiety disorder, a cognitive disorder, a behavioral disorder, or a combination thereof.